2023年美国心脏协会中毒所致心脏骤停及心脏危重症管理指南解读(二):心血管系统药物中毒的管理  

Interpretation of 2023 American Heart Association guideline for the management of patients with cardiac arrest or life-threatening toxicity due to poisoning(Ⅱ):management of cardiovascular substances poisoning

作　　者：廖登勇 褚莉莉 姚鹏[1,2] 谢旭欣 彭爱华 曹钰 LIAO Dengyong;CHU Lili;YAO Peng;XIE Xuxin;PENG Aihua;CAO Yu(Department of Emergency Medicine and Institute of Disaster Medicine,Institute of Emergency Medicine,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,P.R.China;Disaster Medical Center,Sichuan University,Chengdu,Sichuan 610041,P.R.China)

机构地区：[1]四川大学华西医院急诊科,灾难医学研究所/急诊医学研究所,成都610041 [2]四川大学灾难医学中心,成都610041

出　　处：《华西医学》2024年第11期1691-1698,共8页West China Medical Journal

基　　金：成都市科技项目(2022-YF09-00021-SN)。

摘　　要：美国心脏协会于2023年9月18日在Circulation杂志发表了中毒导致心脏骤停及心脏危重症患者的临床管理指南。鉴于指南对临床诊疗的指导作用,作者团队根据药物毒性作用的不同,将其分为3个部分进行详细解读。该文为解读的第2部分,结合文献对指南心脏毒性物质中毒相关的建议进行了解读,主要涉及β受体阻滞剂、钙通道阻滞剂、地高辛等强心苷类以及钠通道阻滞剂中毒的临床管理,期望通过详细解读指南的推荐要点,对同行的诊疗有所帮助。On September 18th,2023,the American Heart Association published clinical management guidelines for patients with poisoning-induced cardiac arrest and critical cardiovascular illness in Circulation.Considering the important role of the guidelines in clinical practice,our team has divided them into three sections for detailed interpretation based on the different toxic effects of the drugs.This article is the second part of the interpretation,which combines the literature to interpret the recommendations related to cardiotoxic substance poisoning in the guidelines,mainly involving the clinical management of beta blockers,calcium channel blockers,digoxin and other cardiac glycosides,as well as sodium channel blocker poisoning,aiming to assist colleagues in their clinical practice through a detailed explanation of the key recommendations in the guidelines.

关 键 词：指南 中毒 心脏骤停 心血管系统药物 复苏 

分 类 号：R595.4[医药卫生—内科学]